Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies
Conclusions: Our study indicates that ovarian cancer considerably alters contractile activity of the nonpregnant human uterus in response to ADRB antagonists. This suggests a pathogenetic role of beta-adrenergic pathways in this malignancy. Furthermore, propranolol and bupranolol substantially influence spontaneous uterine contractility.Gynecol Obstet Invest
Source: Gynecologic and Obstetric Investigation - Category: OBGYN Source Type: research
More News: Academia | Cancer | Cancer & Oncology | Cancer of the Uterus | Cervical Cancer | Endometrial Cancer | Hysterectomy | Inderal | OBGYN | Ovarian Cancer | Ovaries | Study | Women